Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 923093 STAMFORD, CT

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,179,757
+$91,801 QoQ
Shares Held
11,509
-1.0% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#111
of 411 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Derivatives in MDGL

reported options exposure · as of Dec 31, 2025
CallValue
$232,936
CallShares
400
PutValue
$291,170
PutShares
500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. MDGL ranks #13 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MDGL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,179,757 11,509
2026-03-31 $6,087,956 11,630
2025-12-31 $232,936 400
2025-12-31 $291,170 500
2025-12-31 $3,077,666 5,285
2025-09-30 $229,330 500
2025-09-30 $424,719 926
2025-09-30 $366,928 800
2025-06-30 $575,016 1,900
2025-06-30 $332,904 1,100
2025-03-31 $298,107 900
2025-03-31 $364,353 1,100
2024-12-31 $3,186,602 10,327
2024-09-30 $297,108 1,400
2024-06-30 $476,272 1,700
2024-06-30 $952,544 3,400
2024-03-31 $870,016 3,258
2024-03-31 $587,488 2,200
2024-03-31 $320,448 1,200
2023-09-30 $685,219 4,692
2023-06-30 $743,589 3,219
2023-03-31 $3,107,953 12,829
2022-12-31 $2,451,161 8,445
2022-09-30 $508,741 7,828
2022-06-30 $559,540 7,817
2021-12-31 $723,340 8,536